Text-Based Depression Screening for Cancer Survivors

(OASIS1 Trial)

Overseen By Ruby H McGhee, B.A. Psychology

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Medical University of South Carolina

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

Depression is common among cancer survivors, but current screening methods are not always effective. To help improve depression screening for cancer survivors, this study will conduct a pilot randomized controlled trial (RCT) with 60 participants. The goal is to evaluate whether a text message-based approach to depression screening is feasible, acceptable, and potentially more effective than the current standard of care.

Who Is on the Research Team?

Evan Graboyes, MD, MPH, FACS

Principal Investigator

Medical University of South Carolina

Are You a Good Fit for This Trial?

This trial is for cancer survivors who have an upcoming oncology clinic appointment within two weeks, own a cellphone capable of SMS texting, and are proficient in English. It's not specified who cannot participate.

Inclusion Criteria

Upcoming appointment in an HCC or HCN oncology clinic within 14 days

I am over 18 years old.

Ownership of a cellphone with SMS text capability

What Are the Treatments Tested in This Trial?

Interventions

• Text-based depression screening

Trial Overview The study is testing if sending depression screenings via text messages to cancer survivors works better than the usual care methods. This pilot randomized controlled trial will include 60 participants to assess feasibility and effectiveness.

How Is the Trial Designed?

Group I: Text-Based Depression Screening Experimental Treatment 1 Intervention

Group II: Usual Care Active Control 1 Intervention

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials

994

Recruited

7,408,000+